PegBio Co., Ltd.
Status: Publicly traded
Direct answer
PegBio Co., Ltd. is publicly traded on HKSE under the ticker 2565.HK.
PegBio Co., Ltd., a biopharmaceutical company, focuses on the research and development of medicines for chronic diseases in China. Its products include PB-119, a glucagon like peptide 1 receptor agonist for the treatment of type 2 diabetes mellitus and obesity. The company's PB-718 a long-acting GLP-1 receptor agonist, that have completed b/IIa clinical trials for the treatment of non-alcoholic steatohepatitis...
Can you invest in PegBio Co., Ltd.?
Yes. PegBio Co., Ltd. trades publicly on HKSE as 2565.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for PegBio Co., Ltd.
Detailed equity research is provided by MarketSnap.